5-Amino-1MQ Interactions & Stacking
5-Amino-1MQ has 6 documented interactions including 2 synergistic combinations for research stacking.
Interactions & Stacking Compatibility
| Peptide/Compound | Rating | Type | Description |
|---|---|---|---|
| NAD+ Precursors (NMN, NR) | ++ | synergistic | May work synergistically by preventing breakdown while supporting production. |
| Resveratrol | ++ | synergistic | Both support longevity; resveratrol activates sirtuins while 5-Amino-1MQ provides NAD+ substrate. |
| Metformin | ~ | monitor | Both affect metabolic pathways; combination may enhance effects but requires careful monitoring. |
| BPC-157 | + | compatible | No known interactions; different mechanisms with potential complementary benefits. |
| Blood Thinners | ~ | monitor | Limited interaction data; consult healthcare provider before combining. |
| Berberine | ~ | monitor | Both affect metabolic pathways; potential additive glucose metabolism effects. |
Related Peptide Compatibility
| Peptide | Compatibility | Notes |
|---|---|---|
| BPC-157 | compatible | No known interactions; different mechanisms with potential complementary benefits. |
Rating Legend
- ++ = Synergistic — Combined effect greater than individual
- + = Compatible — Safe to combine, additive benefits
- ~ = Monitor — Caution advised, dose adjustment may be needed
- avoid = Contraindicated — Do not combine
Related Sections
- Overview: What Is 5-Amino-1MQ?
Deep Dives: Key Benefits | Mechanism of Action | Research Indications | Dosing Protocols | Side Effects & Safety | What to Expect Timeline | FAQ | References & Studies | Quality Checklist
Product: 5-Amino-1MQ — ≥98% (HPLC verified) · COA available · 5mg / 10mg / 50mg
Disclaimer: This compound is supplied for qualified research and laboratory purposes only. Not for human consumption, therapeutic use, or any application outside controlled research environments.
RaysunPeptide — Southeast Asia-based peptide manufacturer supplying research-grade compounds with HPLC/MS verification and Certificates of Analysis. B2B and qualified research applications.